The agreement with Serf, part of the Mexis Group, would divest Implanet’s Madison knee implant business. The move would allow Implanet to focus entirely on its spine business.
Implanet announced its intent to sell the Madison implant in May 2020.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
